Showing results (281-290 of 515) with videos related to

Sort By:
Pageof 52
Biological Psychiatry Global Open Science|April 13, 2022
Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk SyndromeTina Gupta, Gregory P Strauss, Henry R Cowan, et al.
Early Intervention in Psychiatry|April 12, 2023
The association between early traumatic experiences and the five domains of negative symptoms in participants at clinical high risk for psychosisGifty Ayawvi, Alysia M Berglund, Sydney H James, et al.
Schizophrenia Research|August 6, 2021
Eveningness chronotype preference among individuals at clinical high risk for psychosisJessica R Lunsford-Avery, Andrea Pelletier-Baldelli, Stephanie A Korenic, et al.
Schizophrenia Bulletin Open|July 26, 2021
Prevalence and Functional Consequences of Social Anxiety in Individuals at Clinical High-Risk for Psychosis: Perspective From a Community Sample ComparisonFranchesca S Kuhney, Katherine S F Damme, Andrea Pelletier-Baldelli, et al.
Scientific Reports|May 11, 2021
Psychosis risk individuals show poor fitness and discrepancies with objective and subjective measuresKatherine S F Damme, Richard P Sloan, Matthew N Bartels, et al.
Schizophrenia Research|October 26, 2013
Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosisVijay A Mittal, Joseph M Orr, Jessica A Turner, et al.
Current Treatment Options in Psychiatry|October 17, 2017
Exercise Treatments for Psychosis: A ReviewVijay A Mittal, Teresa Vargas, K Juston Osborne, et al.
Journal of Biomedical Science|July 3, 2013
The cAMP effector EPAC activates Elk1 transcription factor in prostate smooth muscle, and is a minor regulator of α1-adrenergic contractionMartin Hennenberg, Frank Strittmatter, Henning Schmetkamp, et al.
Frontiers in Psychiatry|May 31, 2022
Longitudinal Development of Reasons for Living and Dying With Suicide Attempters: A 2-Year Follow-Up StudyAnja C Gysin-Maillart, Rahel Jansen, Sebastian Walther, et al.
Pageof 52